Author: Bugert, Christina L.; Kwiat, Victoria; Valera, Isela C.; Bugert, Joachim J.; Parvatiyar, Michelle S.
Title: Cardiovascular Injury Due to SARS-CoV-2 Cord-id: y4zi5ufx Document date: 2021_3_5
ID: y4zi5ufx
Snippet: PURPOSE OF REVIEW: The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and fever, the heterogeneity of manifestations is surprising. This review focuses on direct and indirect causes of myocardial injury in COVID-19 patients and highlights current knowledge, treatment strategies, and outstanding questions in the field. RECE
Document: PURPOSE OF REVIEW: The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and fever, the heterogeneity of manifestations is surprising. This review focuses on direct and indirect causes of myocardial injury in COVID-19 patients and highlights current knowledge, treatment strategies, and outstanding questions in the field. RECENT FINDINGS: Data are emerging that highlight the extent of cardiovascular involvement in COVID-19 patients, including evidence that SARS-CoV-2 causes myocarditis and increases cardiac risk. The incidence of cardiac injury is much greater in patients with severe disease presentation and those in intensive care. SUMMARY: During the past year, COVID-19 patient mortality rates have improved due to tailored pharmacological treatments and patient management strategies that address the unique presentation of symptoms, which will hopefully also reduce the incidence of cardiac injury.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute cardiac injury: 1, 2
- ace inhibitor and acute coronary syndrome: 1
- ace inhibitor and acute myocarditis: 1
- ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- ace inhibitor and london hospital: 1
- ace inhibitor and lung alveolar: 1
- ace inhibitor and lung damage: 1
- acs acute coronary syndrome and acute ards respiratory distress syndrome: 1
- acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acs acute coronary syndrome and acute event: 1, 2
- acs acute coronary syndrome and acute illness: 1
- acs acute coronary syndrome and acute myocarditis: 1, 2, 3, 4
- acs acute coronary syndrome and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acs acute coronary syndrome and london hospital: 1
- acs acute coronary syndrome and long term impact: 1
- acs acute coronary syndrome and magnetic resonance: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date